Loading...
Symbols:
Loading...
Symbols:
Regeneron Pharmaceuticals Inc. (REGN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Regeneron Pharmaceuticals Inc. (REGN)
20 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on REGN
- Alan Brochstein(5)
- Zacks.com (4)
- Centient Biotech Investor(3)
- SA Editor Miriam Metzinger(2)
- Jerry Helzner(1)
Most popular authors
(tracked in watchlists)
- Alan Brochstein(132)
- Zacks.com (127)
- SA Editor Miriam Metzinger(116)
- SA Editors(45)
- Lon Juricic(15)
Most commented on authors
- Alan Brochstein(15)
- SA Editor Miriam Metzinger(2)
- A. Reza Saadat(2)
- Zacks.com (2)
- SA Editors(1)
- BioMarin, Myriad, and Regeneron Show a Quiet Strength
- Biotech Sector Continues to Outperform
- ASCO: Whose Presentations Look the Most Promising?
- Five Biotech Stocks to Weather a Down Market
- Biotech Stocks: Sector Outlook and Top Picks
- 2007 Biotech Performance Review
- Keep Your Eye on Regeneron Pharmaceuticals
- Icahn Management Releases Latest 13F: Summary of Holdings
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Biotech Day In Review: Novartis Pulls Zelnorm Off The Market
-
Biotech Day In Review: Regeneron Up On AMD Data
on Mar 28, 2007
- Biotech Day in Review: Xoma Signs $230 Million Partnership with Takeda
- Regeneron: Exciting Technology, Inflated Stock Price
- Biotech Day in Review: Wyeth and AstraZeneca Sign More Deals
-
Analyst Upgrades & Downgrades for Thursday July 27, 2006
on Jul 27, 2006
- One Page Barron's Summary
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »